Search

everythinglearnresearchcommunity

for

Search:↓

Dermatoscopy and videodermatoscopy are useful and reliable for tracking treatment progress in various skin conditions.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Fractional resurfacing is safe and effective for certain skin conditions in Asian patients, but care must be taken to avoid skin pigmentation issues.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Azelaic acid and anthralin are similarly effective for treating patchy hair loss.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

The regenerative solution, tSVF, is a safe and effective treatment for various conditions like aged skin, scars, wounds, and more, but more research is needed to find the best way to use it.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

Finasteride can cause sexual problems and depression in young men.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

Nitrogen mustard was not very effective for hair regrowth in alopecia areata and has potential skin cancer risk.

Stress hormones like cortisol may trigger psoriasis flare-ups.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Avoiding dyed wigs and clothing improved severe allergic reactions in a woman treated with diphencyprone.

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Platelet-rich plasma mesotherapy improved symptoms in patients with corticosteroid-induced rosacea-like dermatitis.

Imiquimod used intravaginally for cervical issues can cause temporary hair loss, especially if severe side effects occur.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

The document describes various skin conditions, their features, and treatments but lacks detailed study size information.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.